Strategy 1: Enhance real-time quantitative data collection and analysis capabilities.
Collect more timely prescription drug-related overdose death data and Emergency Department data to identify possible outbreaks and emerging geographic areas of concern
Conduct more in-depth analysis of PDMP data to better understand prescribing patterns in New York City
Produce and share timely data analysis reports with RxStat partners
Strategy 2: Develop qualitative data collection and analysis capability.
Produce and share timely qualitative data analysis reports with RxStat partners on a quarterly basis describing characteristics of the controlled prescription drug market in different areas of New York City, patterns of use, and information about possible transition to heroin use
Strategy 3: Analyze effects of prescription drug abuse legislation and regulations on RxStat.
Produce and share timely public health policy and legislative updates with RxStat partners on a quarterly basis
Strategy 4: Write and disseminate an RxStat technical assistance manual for other jurisdictions.
Complete manual and related materials within grant period
Strategy 1: Enhance data source collection and analysis.
Add new data sources to RxStat (e.g. Fire Department Emergency Medical Services (EMS), Rikers Island Correctional Facility, Prosecution Data)
Strategy 2: Enhance analysis of prescription opioid supply and prescribing patterns.
Conduct prescriber analysis to include patient and prescription volume. Evaluate changes in prescribing behavior.
Conduct patient-level analysis will be paired with other surveillance analysis (such as overdose mortality) to help describe the demographic characteristics of patients. Data will also be examined for prescription use patterns such as patients visiting multiple prescribers and chronic users of opioid prescriptions.
Strategy 3: Enhance qualitative understanding of how PDMP is utilized by prescribers.
Conduct an in-depth exploration with primary care physicians to examine their experiences using PDMP and how its utilization may influence their prescribing practices and interactions with patients.
Strategy 4: Develop, pilot and evaluate new methods for opioid overdose prevention education and increase access to naloxone for high-risk subpopulations and neighborhoods.
Implement and evaluate naloxone prescribing in two targeted high-risk neighborhoods in NYC, recruiting primary care and emergency department physicians in Staten Island and the South Bronx.
Develop, pilot, and evaluate pharmacy training and dispensing of naloxone in Staten Island and the South Bronx, including the use of electronic training via a mobile device-optimized website.
Train family and friends who visit inmates at Rikers Island on the use of naloxone. The training will be a brief, hands-on module with a curriculum targeted to family and loved ones of incarcerated drug users. Upon completion of the training, individuals will receive an overdose rescue kit (including intranasal naloxone) on site at Rikers Island after their visit.